AdjuvantTherapyBreastCancerBI-RADSPrecisionMedicineAlopeciaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.LumpectomyImmunotherapyGuaranteedRenewableInsuranceWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Co-survivorLymphNodeStatusDoseDenseTherapyPathologicResponseBevacizumabLymphoscintigraphyDown-StagingOligometastasesFibroadenomaMorpheaHormoneReplacementTherapyPI3KinaseInhibitorsLapatinibGermlineMutationCDK4/6InhibitorsMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCystApoptosisMethotrexateDefinitiveSurgeryCachexiaTumorGradePalpationChemotherapyAyurvedaBreastTomosynthesisHormoneReceptorStatusIntraductalPapillomaCMFChemotherapyPalbociclibHerceptinTamoxifenAdenocarcinomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AngiogenesisMRIHER-2AntibodyTherapyPaclitaxelCAMAntiemeticBiopsyNeoadjuvantTherapyBRCAGeneFamilyHistoryRelapseAxillarySamplingOvarianSuppressionCytostaticCapecitabineEstradiolFlowCytometrymTORInhibitorsKappaEpsilonTyrosine-KinaseInhibitorCyclophosphamideFISHER+Physicalactivity mayreduce therisk of breastcancersMegestrolAcetateAnastrozolePARPInhibitorsCytotoxicER-Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltBOCAGenomicTestingMultifocalTumorsECOGScoreMastodyniaBrachytherapy5-FluorouracilWomen ages40+ shouldhave a clinicalbreast examat least yearlySelf-examinationLumpLCISGailModelBilateralProphylacticMastectomyDoxorubicinChemopreventionRADACChemotherapyProgestinGeneticPredispositionStagingDimplingRadiotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerKi-67RateMastectomy1 in 8womenAromataseInhibitorsRaloxifeneGeneticCounselingEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDocetaxelCalcificationsPagetDiseaseIn-situCarcinomaEstrogenSERMPhyllodesTumorMultimodalityTherapyAbsoluteRiskCheckpointInhibitorTriple +/-BreastCancerAdvocacyEGFRGeneMutationAdjuvantTherapyBreastCancerBI-RADSPrecisionMedicineAlopeciaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.LumpectomyImmunotherapyGuaranteedRenewableInsuranceWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Co-survivorLymphNodeStatusDoseDenseTherapyPathologicResponseBevacizumabLymphoscintigraphyDown-StagingOligometastasesFibroadenomaMorpheaHormoneReplacementTherapyPI3KinaseInhibitorsLapatinibGermlineMutationCDK4/6InhibitorsMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCystApoptosisMethotrexateDefinitiveSurgeryCachexiaTumorGradePalpationChemotherapyAyurvedaBreastTomosynthesisHormoneReceptorStatusIntraductalPapillomaCMFChemotherapyPalbociclibHerceptinTamoxifenAdenocarcinomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AngiogenesisMRIHER-2AntibodyTherapyPaclitaxelCAMAntiemeticBiopsyNeoadjuvantTherapyBRCAGeneFamilyHistoryRelapseAxillarySamplingOvarianSuppressionCytostaticCapecitabineEstradiolFlowCytometrymTORInhibitorsKappaEpsilonTyrosine-KinaseInhibitorCyclophosphamideFISHER+Physicalactivity mayreduce therisk of breastcancersMegestrolAcetateAnastrozolePARPInhibitorsCytotoxicER-Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltBOCAGenomicTestingMultifocalTumorsECOGScoreMastodyniaBrachytherapy5-FluorouracilWomen ages40+ shouldhave a clinicalbreast examat least yearlySelf-examinationLumpLCISGailModelBilateralProphylacticMastectomyDoxorubicinChemopreventionRADACChemotherapyProgestinGeneticPredispositionStagingDimplingRadiotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerKi-67RateMastectomy1 in 8womenAromataseInhibitorsRaloxifeneGeneticCounselingEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDocetaxelCalcificationsPagetDiseaseIn-situCarcinomaEstrogenSERMPhyllodesTumorMultimodalityTherapyAbsoluteRiskCheckpointInhibitorTriple +/-BreastCancerAdvocacyEGFRGeneMutation

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Adjuvant Therapy
  2. Breast Cancer
  3. BI-RADS
  4. Precision Medicine
  5. Alopecia
  6. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  7. Lumpectomy
  8. Immunotherapy
  9. Guaranteed Renewable Insurance
  10. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  11. Co-survivor
  12. Lymph Node Status
  13. Dose Dense Therapy
  14. Pathologic Response
  15. Bevacizumab
  16. Lymphoscintigraphy
  17. Down-Staging
  18. Oligometastases
  19. Fibroadenoma
  20. Morphea
  21. Hormone Replacement Therapy
  22. PI3 Kinase Inhibitors
  23. Lapatinib
  24. Germline Mutation
  25. CDK4/6 Inhibitors
  26. Metastasis
  27. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  28. Cyst
  29. Apoptosis
  30. Methotrexate
  31. Definitive Surgery
  32. Cachexia
  33. Tumor Grade
  34. Palpation
  35. Chemotherapy
  36. Ayurveda
  37. Breast Tomosynthesis
  38. Hormone Receptor Status
  39. Intraductal Papilloma
  40. CMF Chemotherapy
  41. Palbociclib
  42. Herceptin
  43. Tamoxifen
  44. Adenocarcinoma
  45. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  46. Angiogenesis
  47. MRI
  48. HER-2
  49. Antibody Therapy
  50. Paclitaxel
  51. CAM
  52. Antiemetic
  53. Biopsy
  54. Neoadjuvant Therapy
  55. BRCA Gene
  56. Family History
  57. Relapse
  58. Axillary Sampling
  59. Ovarian Suppression
  60. Cytostatic
  61. Capecitabine
  62. Estradiol
  63. Flow Cytometry
  64. mTOR Inhibitors
  65. Kappa Epsilon
  66. Tyrosine-Kinase Inhibitor
  67. Cyclophosphamide
  68. FISH
  69. ER+
  70. Physical activity may reduce the risk of breast cancers
  71. Megestrol Acetate
  72. Anastrozole
  73. PARP Inhibitors
  74. Cytotoxic
  75. ER-
  76. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  77. BOCA
  78. Genomic Testing
  79. Multifocal Tumors
  80. ECOG Score
  81. Mastodynia
  82. Brachytherapy
  83. 5-Fluorouracil
  84. Women ages 40+ should have a clinical breast exam at least yearly
  85. Self-examination
  86. Lump
  87. LCIS
  88. Gail Model
  89. Bilateral Prophylactic Mastectomy
  90. Doxorubicin
  91. Chemoprevention
  92. RAD
  93. AC Chemotherapy
  94. Progestin
  95. Genetic Predisposition
  96. Staging
  97. Dimpling
  98. Radiotherapy
  99. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  100. Ki-67 Rate
  101. Mastectomy
  102. 1 in 8 women
  103. Aromatase Inhibitors
  104. Raloxifene
  105. Genetic Counseling
  106. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  107. Docetaxel
  108. Calcifications
  109. Paget Disease
  110. In-situ Carcinoma
  111. Estrogen
  112. SERM
  113. Phyllodes Tumor
  114. Multimodality Therapy
  115. Absolute Risk
  116. Checkpoint Inhibitor
  117. Triple +/- Breast Cancer
  118. Advocacy
  119. EGFR
  120. Gene Mutation